{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/polycystic-ovary-syndrome/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"d45a2f22-c9b6-5ee0-afb6-8ae3d0397d9f","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 56cb3f1f-2bf9-4dc1-9281-9a31c89b94b9 --><h2>Changes</h2><!-- end field 56cb3f1f-2bf9-4dc1-9281-9a31c89b94b9 -->","summary":null,"htmlStringContent":"<!-- begin item 36516d8d-3fd3-4dbc-b945-07b7c4f17d4a --><!-- begin field f7ce7214-1269-40bb-bf19-9433d1521a99 --><p><strong>September 2018</strong> — reviewed. A literature search was conducted in August 2018 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials (RCTs) published since the last revision of this topic. </p><ul><li>Recommendations on the diagnosis of polycystic ovary syndrome (PCOS) in adolescents have been updated in line with recommendations in the <em>International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018</em> issued by the International PCOS Network:<ul><li>When diagnosing PCOS in adolescents, tighter criteria requiring both hyperandrogenism and irregular menstrual cycles is recommended due to the overlap with normal reproductive physiology.</li><li>Ultrasound scan is no longer recommended in the diagnosis of PCOS in those within 8 years of menarche due to the high incidence of multi-follicular ovaries in this life stage.</li><li>Adolescents who have features of PCOS but do not meet the diagnostic criteria should be considered to be at 'increased risk' of PCOS and reassessed at or before full reproductive maturity (8 years post-menarche). This includes those with PCOS features before combined oral contraceptive pill commencement, those with persisting features, and those with significant weight gain in adolescence.</li><li>Irregular menstrual cycles are defined as:<!--_c2a0_21c2a0_days29_                 --><!--_18c2a0_years                 --><ul><li>Normal in the first year post-menarche as part of the pubertal transition.</li><li>More than 1 year to less that 3 years of irregular cycles (more than 45 days or less than 21 days) after the onset of menarche.</li><li>More than 3 years of irregular cycles (more than 35 days or less than 21 days, or less than 8 cycles every year) post-menarche to perimenopause.</li><li>More than 1 year of irregular cycles (more than 90 days for any one cycle) post-menarche.</li><li>Primary amenorrhea by age 15 years or more than 3 years of irregular cycles post thelarche (breast development).</li></ul></li></ul></li><li>The topic has been restructured in light of these changes. </li></ul><!-- end field f7ce7214-1269-40bb-bf19-9433d1521a99 --><!-- end item 36516d8d-3fd3-4dbc-b945-07b7c4f17d4a -->","topic":{"id":"daaf23b6-59bf-5fa9-96d9-6d98f028d2bd","topicId":"90f70ae3-1caf-4e74-8397-cf2655cfb10c","topicName":"Polycystic ovary syndrome","slug":"polycystic-ovary-syndrome","lastRevised":"Last revised in September 2018","chapters":[{"id":"6f41b5a4-2e7e-5469-91c8-15331570cb8c","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5ad66803-f217-58c6-ad92-d9db6491cb26","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"132cf0f7-983a-59b8-aa99-10f350089b7c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"d45a2f22-c9b6-5ee0-afb6-8ae3d0397d9f","slug":"changes","fullItemName":"Changes"},{"id":"e3852569-27c3-5e63-ab2f-2b92dcfe5262","slug":"update","fullItemName":"Update"}]},{"id":"f1fe2489-77fe-5403-977f-d3603e5bae1e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"048d9ada-61af-59a9-971e-42aed733010a","slug":"goals","fullItemName":"Goals"},{"id":"845cd360-b1c4-50ee-a60f-5ec2ce05b2b8","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6bed55f9-2ee7-578e-8770-b9a5e2053955","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"0afb7a34-d84c-5ad9-bcc3-0dc5345cd2b8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f7587b9f-e03a-5ba0-b6c5-173412097eb9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b7749edb-c354-5cb9-adc7-04cbe456d37d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"390c9f6a-9392-5672-8a5d-2945f5be467d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5ae79977-6f68-54e7-bae5-d3a83aa4bad7","slug":"definition","fullItemName":"Definition"},{"id":"86ec422e-1b3a-5c12-b4df-64886e831aea","slug":"causes","fullItemName":"Causes"},{"id":"87943c47-132e-5d7b-bba7-9f5fd8d2fdd8","slug":"prevalence","fullItemName":"Prevalence"},{"id":"fd9eddac-eb60-523a-9a51-e94719b6fef4","slug":"complications","fullItemName":"Complications"},{"id":"104e8e2a-4d4d-5fc6-b68f-5337dd3ccc87","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"26e7fb06-0e4c-5c05-aea8-632061b95e52","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6f9e9e17-1a64-5142-813c-89d3dc869c6d","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"483e27e7-00c5-5c3a-b61b-d00edbcafdd7","slug":"investigations","fullItemName":"Investigations"},{"id":"6a10f0bc-d2b9-504d-beb4-a033a4cfb16b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"82ce27d1-1cdc-5a75-8d26-8bbb3d8d62d7","fullItemName":"Management","slug":"management","subChapters":[{"id":"5c7d454c-e837-5db4-96b6-d7259cedcbb1","slug":"management-adults","fullItemName":"Scenario: Management - adults"},{"id":"762c879d-8353-5b98-98e3-cd5e9dd9238e","slug":"management-adolescents","fullItemName":"Scenario: Management - adolescents"}]},{"id":"980e12cc-a3a7-5006-9004-9a3817403978","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8c324c3d-d93a-5a1b-9a8f-070221373b1a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0096e783-16f8-5f5a-9660-d3685b777a10","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"af33ae46-9b14-5c06-98b3-689fc80c683f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"61bd6f68-6b5a-5980-aec9-07bcbf6dc232","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3d02f180-e5e5-5a10-a991-a415041c663f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"17c9b913-2bf1-5468-a926-0f8643a69cc1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"696b4fff-16f7-5d8a-a5d1-da81a7a53ffc","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"132cf0f7-983a-59b8-aa99-10f350089b7c","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"92c00cef-8e86-5523-85df-d6447f0317b6","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 51569feb-e1b8-4d0b-8190-ce728bb4dbd3 --><h3>Previous changes</h3><!-- end field 51569feb-e1b8-4d0b-8190-ce728bb4dbd3 -->","summary":null,"htmlStringContent":"<!-- begin item ad72740c-26e3-4a39-bae3-5bfd699670b9 --><!-- begin field 970e8ef0-5e2f-47bb-bdbe-30a29c3612df --><p><strong>February to June 2013</strong> — reviewed. A literature search was conducted in February 2013 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials (RCTs) published since the last revision of this topic. New information has been added about when to suspect polycystic ovary syndrome in adolescents, and about emotional well being. The information about the management of infertility has been updated. There are no major changes to the recommendations.</p><p><strong>June 2011</strong> — minor update. Link to the CKS topic on <em>Contraception - combined hormonal methods</em> for a full discussion of the risks of combined oral contraceptives (COCs) added to the management section. Some broken links were also fixed. Issued June 2011.</p><p><strong>March 2011</strong> — topic structure revised to ensure consistency across CKS topics. No changes to clinical recommendations have been made.</p><p><strong>December 2009</strong> — minor update. The choice of COC for women with hirsutism has been updated to be in line with the CKS topic on <em>Hirsutism</em>. Advice to women about the importance of weight loss, if overweight, has been reworded. Issued in December 2009.</p><p><strong>July to October 2009</strong> — converted from CKS guidance to CKS topic structure. The evidence base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There are no major changes to the recommendations.</p><p><strong>July to September 2006</strong> — written. Validated in December 2006 and issued in January 2007.</p><!-- end field 970e8ef0-5e2f-47bb-bdbe-30a29c3612df --><!-- end item ad72740c-26e3-4a39-bae3-5bfd699670b9 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}